Michael Cherny
Stock Analyst at Leerink Partners
(4.28)
# 1,421
Out of 5,090 analysts
571
Total ratings
58%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALGN Align Technology | Reiterated: Buy | $215 → $210 | $149.89 | +40.10% | 22 | Oct 29, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Hold | $145 → $220 | $211.36 | +4.09% | 18 | Oct 29, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $410 | $361.39 | +13.45% | 16 | Oct 29, 2026 | |
| PGNY Progyny | Reiterated: Buy | $37 | $29.19 | +26.76% | 38 | Oct 15, 2026 | |
| HSIC Henry Schein | Reiterated: Hold | $92 | $84.88 | +8.39% | 33 | Oct 14, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $35 → $32 | $23.51 | +36.11% | 25 | Oct 14, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $10 | $9.53 | +4.93% | 35 | Oct 14, 2026 | |
| CVS CVS Health | Reiterated: Buy | $98 → $112 | $90.25 | +24.10% | 67 | Oct 12, 2026 | |
| MDLN Medline | Reiterated: Buy | $43 | $32.12 | +33.87% | 7 | Oct 7, 2026 | |
| ACH Accendra Health | Reiterated: Hold | n/a | $0.2542 | - | 22 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $292 | $250.48 | +16.58% | 39 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.49 | +43.27% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $490 → $620 | $652.01 | -4.91% | 7 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $8 | $11.02 | -27.40% | 16 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $79 → $25 | $32.76 | -23.69% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.68 | - | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $28.00 | +53.57% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $232 → $256 | $267.33 | -4.24% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $251.82 | n/a | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $349 → $361 | $330.84 | n/a | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $994.58 | n/a | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $8.51 | n/a | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $558.88 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $140.05 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.31 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.00 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $12.73 | n/a | 1 | Jan 5, 2022 |
Align Technology
Oct 29, 2026
Reiterated: Buy
Price Target: $215 → $210
Current: $149.89
Upside: +40.10%
ICON Public Limited Company
Oct 29, 2026
Reiterated: Hold
Price Target: $145 → $220
Current: $211.36
Upside: +4.09%
Labcorp Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: $410
Current: $361.39
Upside: +13.45%
Progyny
Oct 15, 2026
Reiterated: Buy
Price Target: $37
Current: $29.19
Upside: +26.76%
Henry Schein
Oct 14, 2026
Reiterated: Hold
Price Target: $92
Current: $84.88
Upside: +8.39%
Envista Holdings
Oct 14, 2026
Reiterated: Buy
Price Target: $35 → $32
Current: $23.51
Upside: +36.11%
DENTSPLY SIRONA
Oct 14, 2026
Reiterated: Hold
Price Target: $10
Current: $9.53
Upside: +4.93%
CVS Health
Oct 12, 2026
Reiterated: Buy
Price Target: $98 → $112
Current: $90.25
Upside: +24.10%
Medline
Oct 7, 2026
Reiterated: Buy
Price Target: $43
Current: $32.12
Upside: +33.87%
Accendra Health
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2542
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: $240 → $292
Current: $250.48
Upside: +16.58%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $3.49
Upside: +43.27%
Jul 23, 2026
Reiterated: Hold
Price Target: $490 → $620
Current: $652.01
Upside: -4.91%
Jun 16, 2026
Reiterated: Buy
Price Target: $13 → $8
Current: $11.02
Upside: -27.40%
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $32.76
Upside: -23.69%
Apr 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $27.68
Upside: -
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $28.00
Upside: +53.57%
Dec 14, 2025
Reiterated: Buy
Price Target: $232 → $256
Current: $267.33
Upside: -4.24%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $251.82
Upside: n/a
Oct 6, 2025
Reiterated: Buy
Price Target: $349 → $361
Current: $330.84
Upside: n/a
Oct 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $994.58
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $8.51
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $558.88
Upside: n/a
Sep 4, 2024
Reiterated: Hold
Price Target: n/a
Current: $140.05
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.31
Upside: n/a
Jun 14, 2023
Reiterated: Buy
Price Target: $22
Current: $5.00
Upside: n/a
Jan 5, 2022
Reiterated: Hold
Price Target: $7.5
Current: $12.73
Upside: n/a